Navigation Links
Marketing and Meeting Details (M2D) Officially Launches an Innovative Life Sciences Marketing and Communications Company
Date:11/19/2007

Clients to Benefit from a Distinctive Union of Pharmaceutical, Biotech and Medical Device Experience in Professional Education, Brand Management and

Special Event Planning

NORTH BRANFORD, Conn., Nov. 19 /PRNewswire/ -- M2D management announces the official launch of a progressive marketing and communications firm that will focus on the life sciences sector. M2D is the brainchild of two individuals with clear records of success in this highly regulated sector, Christine Lawton and Timothy Roe.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071119/NEM104LOGO )

Christine is a respected meetings and events professional with almost two decades of experience working on both the client and agency sides of the business. Her accomplishments span several hundred meetings and conventions of all varieties, both domestically and internationally, during her pharmaceutical tenure.

Timothy is a pharmaceutical and medical device professional with over 15 years of progressively responsible positions in Sales and Marketing. Timothy is known in the industry as having the business acumen to maximize a product's global commercial return and asset value. Timothy has managed the "Big-C" brands, Celebrex(R), Cipro(R) and Clarinex(R) as well as several smaller niche products.

M2D provides tireless proactive thinking that eliminates problems associated with vendor complacency. Timothy Roe adds:

"As a former Product Manager, I recognize what is important to clients. Vendors should always add more detailed and proactive thought to their work, even after the 'honeymoon' period. There continues to be a tremendous need for much higher performance, and smaller firms like M2D are already there. Those who can do it cost-effectively will win."

M2D's uniqueness results from a lifetime of client-side interactions with vendors. Clients receive genuine strategic attention, but the difference lies with M2D's painstakingly detailed approach to tactical execution. The company utilizes the most advanced analytics and metric reporting tools available and offers them either gratis or at attractive pricing.

M2D's core capabilities include:

-- Thorough Understanding of Compliance Laws

-- Lowest Guaranteed Travel Rates

-- Investigator & Sales Meetings

-- Conventions & Symposia; Ad Boards & Round Tables

-- Opinion Leader & Speaker Bureau Management

-- Promotional Peer-to-Peer Events

-- CME-based Programming

-- Surrogate Brand Management and Audits

-- Advanced Webinars & Web Conferences with Real-Time Polling

M2D's website http://www.m2details.com.

Celebrex, Cipro and Clarinex are products of Pfizer, Bayer and Schering- Plough respectively.

Contact: M2D Media Relations

Phone: 781-210-4710

Fax: 781-210-4711

Email: MediaRelations@m2details.com


'/>"/>
SOURCE Marketing and Meeting Details (M2D)
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
2. Innocoll Agrees the Sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European Sales and Marketing Infrastructure to EUSA Pharma
3. Crdentias VP of Marketing, Christina Hogan, Provides Exclusive Interview on Marketing Strategy
4. Fitness Champion Natalie Waples to be Spokesperson for Natural Nutrition International Direct Marketing Campaign
5. Roy Jakobs Appointed Elsevier Managing Director, A&G Sales and Customer Marketing
6. Milestone Scientific Names Robert Presutti New Vice President of Sales and Marketing
7. Sterling Life Enhances Marketing Operations Controls to Better Serve Medicare Beneficiaries
8. Former Ronco President Tim Dupler Signs International Direct Sales and Marketing Contract with Natural Nutrition
9. Eastern Alliance Insurance Group Appoints Cox Regional Marketing Director for Southeast
10. Bristol-Myers Squibb Finalizes Settlement of Previously Disclosed Federal Investigation into Pricing, Sales and Marketing Practices
11. Scientific Publications Strategy & Delivery Shifts from Marketing to Medical
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/20/2017)... ... ... A new partnership between Goodwill® and Roadie, Inc. aims to make it easier ... couches to dressers and bicycles. Roadie — the national on-the-way delivery network — will ... through February 28th. , “January is an exciting time when resolutions are made ...
(Date:1/20/2017)... FL (PRWEB) , ... January 20, 2017 , ... Source ... botanicals and 100 percent pure essential oils, announced the company had a successful visit ... , The annual ECRM event gives companies that work in the nutritional, sports and ...
(Date:1/20/2017)... (PRWEB) , ... January 20, 2017 , ... Bionic Sports ... all walks of life, announced it had a successful January ECRM Trade Show in ... in the United States, which allows it to provide its products to all clients ...
(Date:1/20/2017)... ... January 20, 2017 , ... ATP Science, an Australian-based company ... attended the January ECRM Trade Show in Hilton Head, SC, benefiting from outstanding ... range of supplements that keep the body functioning at its peak performance by ...
(Date:1/20/2017)... boca raton florida (PRWEB) , ... January 20, 2017 , ... ... trial at the Dana Farber Cancer Institute. For Betsy, the clinical trial has ... and her cancer has not worsened. , Betsy Brauser was diagnosed with ovarian ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... CITY, Calif. , Jan. 19, 2017  Abaxis, ... company manufacturing point-of-care blood analysis instruments and consumables for ... conference call to discuss its financial results for the ... The call will be at 4:15 p.m. ET on ... results for the third quarter fiscal year 2017 after ...
(Date:1/19/2017)... , Jan. 19, 2017  Sensus Healthcare, Inc. ... company specializing in the treatment of non-melanoma skin ... with superficial radiation therapy, today announced that it ... 2016 financial results on Thursday, February 2, 2017 after ... hold a conference call with the investment community ...
(Date:1/19/2017)... LEXINGTON, Massachusetts , January 19, 2017 ... SHPG ) announced that the U.S. Food and Drug ... resubmission of a New Drug Application (NDA) for SHP465, ... being evaluated as a potential once-daily treatment for Attention-Deficit/Hyperactivity ... decision on or around June 20, 2017, the designated ...
Breaking Medicine Technology: